SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-040574
Filing Date
2020-12-03
Accepted
2020-12-02 19:41:19
Documents
3
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea130801-6k_chinasxtpharma.htm 6-K 34846
2 FORM OF VOTING AGREEMENT, DATED NOVEMBER 24, 2020, BY AND BETWEEN XING YUAN AND ea130801ex4-1_chinasxt.htm EX-4.1 45661
3 FORM OF SPA, DATED NOVEMBER 24, 2020, BY AND BETWEEN THE COMPANY AND XING YUAN ea130801ex10-1_chinasxt.htm EX-10.1 263301
  Complete submission text file 0001213900-20-040574.txt   344794
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 201365290
SIC: 2834 Pharmaceutical Preparations